<b>Conclusions</b>: The concurrent administration of RES and AG490 effectively inhibited the JAK2/STAT3 signalling pathway and enhanced antitumor effects in GBM cells, indicating their potential as a therapeutic strategy. This evidence concerns the gene JAK2 and glioblastoma.